Trial intelligence / Profile preview

EV71 Inactivated Vaccine (Vero Cell) Effectiveness in Children

CTR20201119Phase 4Active

Sponsor
Wuhan Institute of Biological Products
Start
Jun 2020
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Inactivated Enterovirus Type 71 Vaccine (Vero Cell) in enterovirus 71 infection, sponsored by Wuhan Institute of Biological Products. Started Jun 2020; status: active.

02

Drugs

Inactivated Enterovirus Type 71 Vaccine (Vero Cell)
03

Conditions

enterovirus 71 infection

Beyond the preview

Go deeper on CTR20201119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20201119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call